|
private:eyenuk
|
2731060
|
Jan 11th, 2023 12:00AM
|
Eyenuk, Inc.
|
3.5K
|
29.00
|
Open
|
Medical Device
|
Jan 11th, 2023 12:28AM
|
Jan 11th, 2023 12:28AM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Dec 19th, 2022 12:00AM
|
Eyenuk, Inc.
|
3.4K
|
29.00
|
Open
|
Medical Device
|
Dec 18th, 2022 08:53PM
|
Dec 18th, 2022 08:53PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Nov 22nd, 2022 12:00AM
|
Eyenuk, Inc.
|
3.4K
|
29.00
|
Open
|
Medical Device
|
Nov 22nd, 2022 02:26AM
|
Nov 22nd, 2022 02:26AM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Oct 11th, 2022 12:00AM
|
Eyenuk, Inc.
|
3.1K
|
30.00
|
Open
|
Medical Device
|
Oct 11th, 2022 11:57AM
|
Oct 11th, 2022 11:57AM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Aug 30th, 2022 12:00AM
|
Eyenuk, Inc.
|
2.7K
|
31.00
|
Open
|
Medical Device
|
Aug 29th, 2022 08:14PM
|
Aug 29th, 2022 08:14PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Aug 9th, 2022 12:00AM
|
Eyenuk, Inc.
|
2.6K
|
28.00
|
Open
|
Medical Device
|
Aug 9th, 2022 11:05AM
|
Aug 9th, 2022 11:05AM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Jul 2nd, 2022 12:00AM
|
Eyenuk, Inc.
|
2.5K
|
27.00
|
Open
|
Medical Device
|
Jul 1st, 2022 08:27PM
|
Jul 1st, 2022 08:27PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
Jun 13th, 2022 12:00AM
|
Eyenuk, Inc.
|
2.5K
|
26.00
|
Open
|
Medical Device
|
Jun 13th, 2022 12:11PM
|
Jun 13th, 2022 12:11PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
May 29th, 2022 12:00AM
|
Eyenuk, Inc.
|
2.5K
|
26.00
|
Open
|
Medical Device
|
May 29th, 2022 04:14PM
|
May 29th, 2022 04:14PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|
|
private:eyenuk
|
2731060
|
May 17th, 2022 12:00AM
|
Eyenuk, Inc.
|
2.5K
|
26.00
|
Open
|
Medical Device
|
May 16th, 2022 11:20PM
|
May 16th, 2022 11:20PM
|
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
|
Open
|
Medical image analysis, Consumer vision, Ophthalmic medical devices, Diabetic retinopathy, Telemedicine, Age Related Macular Degeneration, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Ophthalmology, Optometry, Optical, Cataract, Artificial intelligence, Machine learning, Diabetes, Medical device, Digital health, Fundus imaging
|
Open
|
5850 Canoga Ave., Suite 250
|
Los Angeles
|
CA
|
US
|
91367
|
|
Eyenuk
|
Health Care
|
Health Care Equipment & Services
|